Company Filing History:
Years Active: 2005-2017
Title: Elisabeth Sauzeat: Innovator in Vaccine Composition
Introduction
Elisabeth Sauzeat is a prominent inventor based in Lentilly, France. She has made significant contributions to the field of vaccine development, holding 2 patents that focus on innovative vaccine compositions. Her work is crucial in advancing immunization strategies and enhancing vaccine efficacy.
Latest Patents
Elisabeth's latest patents include a vaccine composition with aluminium hydroxide nanoparticles. This invention comprises at least one antigen and one adjuvant, characterized by sterile-filterable nanoparticles that include pseudo-boehmite and polyacrylate. Another notable patent is a vaccine composition that utilizes iron phosphate as a vaccine adjuvant. This composition features iron phosphate in particle sizes ranging from 0.01 µm to 300 µm, which can be produced by mixing a solution of iron salt and phosphate salt.
Career Highlights
Throughout her career, Elisabeth has worked with leading companies in the pharmaceutical industry, including Sanofi Pasteur Inc. and Sanofi Pasteur SA. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in vaccine technology.
Collaborations
Elisabeth has collaborated with notable colleagues such as Yannick Mathieu and Benedicte Lebeau. These partnerships have fostered a collaborative environment that enhances innovation and research in vaccine development.
Conclusion
Elisabeth Sauzeat's contributions to vaccine composition are invaluable in the ongoing fight against infectious diseases. Her innovative patents and collaborations highlight her commitment to advancing public health through scientific research.